ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Simnotrelvir
C22H30F3N5O4S2
549.6 g/mol
API

(S)-N-((S)-1-Cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-7-((S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxamide

CAS2920904-06-7
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

This compound is a synthetic active pharmaceutical ingredient featuring a spirocyclic dithiane core with multiple amide groups and a nitrile moiety. It is primarily significant as a chemical entity used in pharmaceutical manufacturing and research, with its structure incorporating stereochemical precision for targeted applications.

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ReferenceSame Category

Methylprednisolone hemisuccinate

CAS2921-57-5

pharmaceutical raw material

ReferenceSame Category

Mequitazine

CAS29216-28-2

pharmaceutical raw material

ReferenceSame Category

N-nitroso-quinapril

CAS2922985-13-3

pharmaceutical raw material

ReferenceSame Category

Gimatecan

CAS292618-32-7

pharmaceutical raw material

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(8S)-N-[(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]-7-[(2S)-3,3-dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butanoyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxamide

InChIKey

LQBRGTAIBBFUJJ-ZQDZILKHSA-N

SMILES

CC(C)(C)[C@@H](C(=O)N1CC2(C[C@H]1C(=O)N[C@@H](C[C@@H]3CCNC3=O)C#N)SCCS2)NC(=O)C(F)(F)F

Synonyms (2)

—

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→